METHOTREXATE TABLETS, USP
METHOTREXATE TABLETS, USP
Approved
DIN Number
02182750
Drug Class
Human
Market Date
Apr 12, 2004
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02182750
AIG Number0107545004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01BA01 METHOTREXATE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
METHOTREXATEActive
Strength: 10 MG
Monograph: METHOTREXATE